Anti-Spike RBD Antibody (Regdanvimab)
Catalog No.
F1014
Anti-Spike RBD Antibody (Regdanvimab)
Featured Products
Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor binding domain of the SARS-CoV-2 spike protein, blocking the interaction with ACE2 to prevent viral entry. Regdanvimab can be used in COVID-19 research.
146.22 kDa
Dry ice
2444308-95-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
CT-P59, Regkirona, CT-P-59, IN-006
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Spike RBD
Please avoid freeze-thaw cycles.